Global Biotechnology Instruments Market Overview

The Global Biotechnology Instruments market was valued at USD 43.21 billion in 2021 and is expected to reach USD 62.44 billion by the year 2028, at a CAGR of 5.4%.

Human civilization has been harnessing biological processes to enhance their standard of living for some 10,000 years, beginning with the first agricultural communities. Approximately 6,000 years ago, humans utilized the biological methods of microorganisms to make alcoholic beverages, bread, cheese, and to preserve dairy products. Recently, due to the advent of biotechnology instruments, all these processes have become effortless and new technologies have been discovered to increase the yield.

Biotechnology is any technological application that incorporates the usage of biological systems, living organisms, or derivatives thereof, to manufacture or to upgrade products or processes for specific use. Furthermore, the field of biotechnology instruments has observed a tremendous rise since the start of the Human Genome Project in 1990. Although the biotechnology instrument industry existed before the start of the project, it was the Human Genome Project with its major access to key universities, national laboratories, and government funding sources that gave great acceleration to the field thus, stimulating the growth of the Biotechnology Instruments Market in the late 20th century. Moreover, the tremendous growth in technology has increased the complexity of instruments. These modern-day sophisticated biotechnology instruments are utilized for the production of vaccines, developing novel therapies and diagnostics tests, gene modifications, and are almost employed in every life science-related field thus, promoting the extension of biotechnology instruments throughout the forecast. The usage of biotechnology in the agriculture sector led to the rise of transgenic crops that have high yields and resistant qualities to pests and diseases. Moreover, Biotechnology instruments can also be employed to degrade toxic or harmful chemicals and agents to solve environmental problems thus, promoting the growth of the biotechnology instruments in the period of forecast.

COVID-19 Impact on Biotechnology Instruments Market

The outbreak of COVID-19 has severely affected the functioning of several industries. To prevent the transmission of COVID-19 disease several governments declared shutdown of the country. Moreover, the consequences of the shutdown resulted in disruptions of the supply chain, import and exports of commodities, and a sharp decline in the production of several goods. The COVID-19 pandemic has increased the demand for PCR tests as there are only tests available to detect the presence of the SARS CoV-2 virus. Moreover, the demand for medicines to treat symptoms and vaccines to boost immunity, significantly increased in the pandemic era thus, to manufacture these essential commodities on large scale, biotechnology instruments were incorporated. Furthermore, various methods were administered to decipher the genetic code and to develop medicines and vaccines effective against the virus. As a result of the pandemic, administrations have shifted their focus to infectious disease research and to discover novel therapies and diagnostics tests for new clinical groups depending on age and sex. Furthermore, pandemics made researchers realize immunology is central to all and to apply to all diseases. There is hope for even more ground-breaking solutions in the future if companies are innovative and eager to rethink their research thus COVID-19 pandemic has boosted the development of the biotechnology instruments market.

Market Dynamics And Key Factors In Biotechnology Instruments Market

Drivers:

With the rise in technological advancements and the increasing knowledge in the biotechnology sector, the demand for biotechnology instruments has significantly grown. Moreover, in healthcare and pharmaceutical applications, biotechnology has boosted the development and discovery of advanced medicines, therapies, diagnostics, and vaccines. Furthermore, breakthroughs in biotechnological techniques have generated new medicines for patients suffering from growth diseases, metabolic diseases, multiple sclerosis (MS), rheumatoid arthritis, cancer, and Alzheimer's disease thus driving the expansion of the Biotechnology Instruments Market during the forecast period.

In other sectors such as agriculture, livestock, veterinary, and aquaculture, biotechnology has enhanced animal feed, produced broad-spectrum vaccines for livestock, and improved diagnostic techniques for detecting diseases such as Bovine spongiform encephalopathy (BSE), foot and mouth disease, and salmonella with the help of advance biotechnology instruments. Furthermore, biotechnology instruments have also enabled the efficient usage of enzymes for food processing and improved the breeding of plants to obtain required characteristics thus, stimulating the growth of the Biotechnology Instruments Market in the forecast period.

In industrial processes and manufacturing, with the advent of biotechnology instruments, the incorporation of enzymes in the production of detergents, pulp and paper, textiles, and biomass has been achieved. Moreover, by utilizing fermentation and enzyme biocatalysis instead of traditional chemical synthesis, higher process efficiency and reduction in energy and water consumption can be obtained. This process leads to less release of toxic waste thus, encouraging the expansion of the Biotechnology Instruments Market throughout the forecast.

Restraints:

The growing concern about genetically modified crops and the adverse side effects on human health is hampering the usage of biotechnology instruments in the agricultural sector. Furthermore, the minute chances of leakage of certain harmful viruses and bacteria from research institutions is still a matter of concern questioning the effectiveness of biotechnology instruments. The popularity of biotechnology instruments has created some counterfeit instruments that can create a hazard while handling some harmful microorganisms thus hindering the expansion of the biotechnology instruments market. Moreover, as biotechnology instruments are utilized for the production of vaccines, the same instruments can be employed for the production of harmful viruses that can have a huge negative impact on human health and can create a huge economic crisis. The usage of biotechnology instruments in the agricultural sector can spread crop diseases contaminating the natural gene pool of specific crop species thus, restricting the growth of the Biotechnology Instruments Market in the forecast period.

Opportunities:

Nanotechnology is a multidisciplinary sector that incorporated the usage of nano-sized particles and devices for various applications such as diagnostics, targeted drug delivery, and the production of new therapeutic materials. Nanoparticles such as gold and silver have been utilized in biomedical and diagnostic applications, for the detection of viral particles for certain instances. Nanotechnology has proven to aid in treating viral infection by modes of various mechanisms. Moreover, the employment of nanotechnology in the development of new medicines has been acknowledged as a key enabling technology, capable of offering new and innovative medical solutions to address unmet medical needs. Thus, providing tools required for nanotechnological processes is an essential opportunity for the market players.

In the case of Covid-19, it took two weeks for public health officials to report the virus to the World Health Organization (WHO), and for scientists to isolate the virus and decipher the full genetic sequence. The discovery of this genetic code may elucidate the origins and the transmission of the disease, and also point to potential pharmaceutical targets for drug development. Time is of the essence on the frontline of this viral outbreak, therefore advancements in gene-editing technologies, particularly in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas9 (CRISPR-associated protein 9) may need to be harnessed in chronological order to accelerate the ongoing efforts to develop drugs and diagnostics. The significant effects of gene editing and the utilization of CRISPR-Cas9, Zinc Finger Nucleases, and other techniques for this method are a hotspot for market players.

Market Segmentation

Segmentation Analysis of Biotechnology Instruments Market:

Depending on Products, the life science consumables segment is anticipated to lead the Biotechnology Instruments Market during the period of forecast. The life science consumable is a vast field that includes research in food, forensic, cancer, and proteomics fields. Additionally, it also includes, nanobiotechnology, drug discovery, toxicology, veterinary, immunobiology, animal and plant tissue cultures. The rapid development in biotechnology instruments has boosted the growth of this segment. Moreover, various novel techniques have been discovered that can cure cancer and other life-threatening diseases which were previously declared to be fatal thus, supporting the growth of the life science consumables segment in the forecast period.

Depending on the Technology, the spectroscopy segment is expected to dominate the Biotechnology Instruments Market. Mass spectrometry is a type of spectroscopy, having wide application in diverse fields such as forensic toxicology, metabolomics, proteomics, pharma, biopharma, and clinical research. Moreover, drug testing and discovery, food contamination detection, pesticide residue analysis, isotope ratio determination, protein identification, and carbon dating are some specific applications of mass spectrometry thus driving the growth of this segment in the forecast period. The PCR segment is forecasted to grow at a significant growth rate attributed to the increasing applications of PCR in the forensic and life science field. The need for accurate diagnostics of certain viral diseases in a short period such as influenza and SARS CoV-2 is propelling the growth of the PCR segment.

Depending on Applications, the Biotechnology Instruments Market is segmented into clinical and research. The research segment is expected to have the highest share of the Biotechnology Instruments Market. The main driving factor of this segment is the rise in the worldwide fundings done by numerous governments to discover novel technologies to increase the yield of agricultural products, to develop novel efficient therapies to treat diseases, and to manufacture vaccines to control outbreaks of various diseases. Biotechnology instruments provide a safe and reliable atmosphere for research work thus, promoting the growth of this segment.

Depending on End-Users, the Pharma-Biotech segment is predicted to have the highest share of the Biotechnology Instruments Market throughout the forecast. Pharmaceutical companies are widely known for producing pharmaceutical drugs. These drugs are utilized to diagnose, cure, treat, and prevent diseases. According to Statista, the pharmaceutical industry is one of the largest sectors, with the global pharmaceutical market estimated nearly at 1.3 trillion U.S. dollars in 2020. Moreover, pharma companies are involved not only in the pure pharmaceutical business, but also produce medical technology and vaccines, and consumer health products with the usage of biotechnology instruments. Furthermore, there are both authenticate biotechnology companies as well as pharmaceutical companies which among other commodities also manufacture biotech products within their biotechnological divisions. Top leading global pharmaceutical companies have their biopharmaceutical divisions. Roche, a biotech-pharma company from Switzerland has the highest revenues from biotechnology products worldwide even though it is not a completely biotech company. Biotech companies use biotechnology instruments to generate their products, which are mostly medical drugs and genetically engineered crops.

Regional Analysis of Biotechnology Instruments Market:

The North American region is anticipated to lead the growth of the Biotechnology Instruments Market in the forecast period. The presence of major companies and highly skilled professionals are the major factors driving the Biotechnology Instruments Market growth in this region. Moreover, countries such as the US, and Canada have made huge amounts of funding for the technological advancements in biotechnology instruments to improve the diagnostics process and to enhance the research-oriented work for the findings of novel techniques to treat cancer and other deadly diseases. Furthermore, many companies in this region have collaborated to solve socio-economic and environmental challenges thus, encouraging the growth of Biotechnology Instruments in the North American region.

Asia-Pacific region is expected to grow at the highest growth rate in the forecast period. The collaborations with the multinational companies and the investments made by them for the establishment of manufacturing utilities is the main driving factor in this region. Moreover, the growing inclination of countries such as China, India, Japan, and Australia towards the advantageous effects of the utilization of biotechnology instruments in industrial, agriculture, energy, and environmental processes is promoting the expansion of the biotechnology instruments market. According to India Brand Equity Foundation (IBEF), the Indian biotechnology sector estimated US$ 63 billion in 2019 and is expected to reach US$ 150 billion by 2025, with a CAGR of 16.4%. Moreover, the contribution of the Indian biotechnology industry in the global biotechnology market is expected to grow to 19% by 2025 from 3% in 2017, thus supporting the development of the Biotechnology Instruments Market in the period of forecast.

The European region is forecasted to grow at a significant growth rate during the forecast period. The growing adoption of biotechnology-derived techniques for the production of medicines genetically modifies crops, and advanced laser technologies to treat cancer, Parkinson's, and other neurological disorders are the vital factors strengthening the expansion of the Biotechnology Instruments Market in the forecast period. Moreover, the increasing fundings for the development of the biotechnology sector by various governments and the presence of world-renowned health institutions are fueling the Biotechnology Instruments Market growth in this region.

Players Covered in Biotechnology Instruments market are :

  • Abbott
  • Agilent Technologies
  • Alcon Inc.
  • AngioDynamics
  • Becton
  • Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories
  • BioTek Instruments Inc.
  • Candela Medical
  • Cynosure LLC
  • Danaher Corporation
  • Endress+Hauser (Analytik Jena GmbH)
  • F. Hoffmann-La Roche Ltd.
  • IIlumina Inc.
  • IRIDEX
  • Lumenis
  • Merck KGaA
  • Novanta Inc.
  • Perkin Elmer Inc.
  • QIAGEN
  • Siemens Healthineers
  • Tecan Group AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • Zimmer MedizinSysteme and other Major Players.

Key Industry Developments In Biotechnology Instruments Market

  • In August 2021, BD (Becton, Dickinson, and Company), a leading global medical technology company, declared the inauguration of a new, completely automated high-throughput diagnostic system utilizing sample management software algorithms and robotics to establish a new standard in automation for infectious disease molecular testing in the United States for core laboratories and other centralized laboratories.
  • In July 2021, Agilent Technologies Inc. declared the launch of an optimized and verified method for PFAS Analysis in Water by triple quadrupole for liquid chromatography (LC/TQ) for testing per and poly-fluoroalkyl substances (PFAS) in surface and drinking water by employing mass spectrometry and liquid chromatography. With the usage of Agilent's PFAS drinking and surface water solution, customers can run real samples within hours, eradicating the need for an extensive investigation, optimization, and method development that usually take weeks.
  • In July 2021, Bio-Rad Laboratories, Inc., a leading company in life science research and clinical diagnostic products, collaborated with Seegene, Inc., a global leading company in multiplex molecular diagnostics, for the clinical growth and commercialization of infectious disease molecular diagnostic solutions. With this agreement, Seegene will supply diagnostic tests for usage on Bio-Rad's CFX96™ Dx Real-Time PCR System for U.S. markets.
  • In June 2021, Hitachi High-Tech Corporation declared the launch of AFM100 and AFM100 Plus systems, entry-level and intermediate-level prototypes of Hitachi's compact and multi-purpose Atomic Force Microscopes (AFM). These tools are developed to provide ease of usage and superior reliability for high-throughput R&D or quality control applications.

Global Biotechnology Instruments Market

Base Year:

2021

Forecast Period:

2022-2028

Historical Data:

2016 to 2020

Market Size in 2021:

USD 43.21 Bn.

Forecast Period 2022-28 CAGR:

5.4%

Market Size in 2028:

USD 62.44 Bn.

Segments Covered:

By Product Type

  • Life Science Consumables
  • IVD Instruments
  • Medical Lasers
  • Lab Automation Instruments

By Technology

  • Spectroscopy
  • Polymerase Chain Reaction {PCR}
  • Liquid Handling
  • Next-Generation Sequencing
  • Electrophoresis
  • Chromatography
  • Cell Counting
  • Others

By End Users

  • Pharma-Biotech
  • Agri And Food Industry
  • Hospitals
  • Bioinformatics
  • Diagnostic Labs

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Growing Demand for Biotechnology Instruments in Various Sectors

Key Market Restraints:

  • High Cost of Biotechnology Instrument

Key Opportunities:

  • Growing Technological Advancement

Companies Covered in the report:

  • Agilent Technologies, Inc. (the US), BD (Becton, Dickinson, and Company) (US), Bio-Rad Laboratories, Inc. (the US), Bruker (US), Danaher (US), and other major players.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product Type
 3.2 By Technology
 3.3 By End-Users

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Biotechnology Instruments Market by Product Type
 5.1 Biotechnology Instruments Market Overview Snapshot and Growth Engine
 5.2 Biotechnology Instruments Market Overview
 5.3 Life Science Consumables
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Life Science Consumables: Grographic Segmentation
 5.4 In-Vitro Diagnostics {IVD} Instruments
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 In-Vitro Diagnostics {IVD} Instruments: Grographic Segmentation
 5.5 Medical Lasers
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Medical Lasers: Grographic Segmentation
 5.6 Lab Automation Instruments
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Lab Automation Instruments: Grographic Segmentation

Chapter 6: Biotechnology Instruments Market by Technology
 6.1 Biotechnology Instruments Market Overview Snapshot and Growth Engine
 6.2 Biotechnology Instruments Market Overview
 6.3 Spectroscopy
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Spectroscopy: Grographic Segmentation
 6.4 Polymerase Chain Reaction {PCR}
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Polymerase Chain Reaction {PCR}: Grographic Segmentation
 6.5 Liquid Handling
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Liquid Handling: Grographic Segmentation
 6.6 Next-Generation Sequencing
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Next-Generation Sequencing: Grographic Segmentation
 6.7 Electrophoresis
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Electrophoresis: Grographic Segmentation
 6.8 Chromatography
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size (2016-2028F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 Chromatography: Grographic Segmentation
 6.9 Cell Counting
  6.9.1 Introduction and Market Overview
  6.9.2 Historic and Forecasted Market Size (2016-2028F)
  6.9.3 Key Market Trends, Growth Factors and Opportunities
  6.9.4 Cell Counting: Grographic Segmentation
 6.10 Others
  6.10.1 Introduction and Market Overview
  6.10.2 Historic and Forecasted Market Size (2016-2028F)
  6.10.3 Key Market Trends, Growth Factors and Opportunities
  6.10.4 Others: Grographic Segmentation

Chapter 7: Biotechnology Instruments Market by End-Users
 7.1 Biotechnology Instruments Market Overview Snapshot and Growth Engine
 7.2 Biotechnology Instruments Market Overview
 7.3 Pharma-Biotech
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Pharma-Biotech: Grographic Segmentation
 7.4 Agri & Food Industry
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Agri & Food Industry: Grographic Segmentation
 7.5 Hospitals
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Hospitals: Grographic Segmentation
 7.6 Bioinformatics
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Bioinformatics: Grographic Segmentation
 7.7 Diagnostic Labs
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Diagnostic Labs: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Biotechnology Instruments Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Biotechnology Instruments Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Biotechnology Instruments Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 ABBOTT
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 AGILENT TECHNOLOGIES
 8.4 ALCON INC.
 8.5 ANGIODYNAMICS
 8.6 BECTON
 8.7 DICKINSON AND COMPANY
 8.8 BIOMERIEUX SA
 8.9 BIO-RAD LABORATORIES
 8.10 BIOTEK INSTRUMENTS INC.
 8.11 CANDELA MEDICAL
 8.12 CYNOSURE LLC
 8.13 DANAHER CORPORATION
 8.14 ENDRESS+HAUSER (ANALYTIK JENA GMBH)
 8.15 F. HOFFMANN-LA ROCHE LTD.
 8.16 IILUMINA INC.
 8.17 IRIDEX
 8.18 LUMENIS
 8.19 MERCK KGAA
 8.20 NOVANTA INC.
 8.21 PERKIN ELMER INC.
 8.22 QIAGEN
 8.23 SIEMENS HEALTHINEERS
 8.24 TECAN GROUP AG
 8.25 THERMO FISHER SCIENTIFIC INC.
 8.26 WATERS CORPORATION
 8.27 ZIMMER MEDIZINSYSTEME
 8.28 OTHER MAJOR PLAYERS

Chapter 9: Global Biotechnology Instruments Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Product Type
  9.2.1 Life Science Consumables
  9.2.2 In-Vitro Diagnostics {IVD} Instruments
  9.2.3 Medical Lasers
  9.2.4 Lab Automation Instruments
 9.3 Historic and Forecasted Market Size By Technology
  9.3.1 Spectroscopy
  9.3.2 Polymerase Chain Reaction {PCR}
  9.3.3 Liquid Handling
  9.3.4 Next-Generation Sequencing
  9.3.5 Electrophoresis
  9.3.6 Chromatography
  9.3.7 Cell Counting
  9.3.8 Others
 9.4 Historic and Forecasted Market Size By End-Users
  9.4.1 Pharma-Biotech
  9.4.2 Agri & Food Industry
  9.4.3 Hospitals
  9.4.4 Bioinformatics
  9.4.5 Diagnostic Labs

Chapter 10: North America Biotechnology Instruments Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Product Type
  10.4.1 Life Science Consumables
  10.4.2 In-Vitro Diagnostics {IVD} Instruments
  10.4.3 Medical Lasers
  10.4.4 Lab Automation Instruments
 10.5 Historic and Forecasted Market Size By Technology
  10.5.1 Spectroscopy
  10.5.2 Polymerase Chain Reaction {PCR}
  10.5.3 Liquid Handling
  10.5.4 Next-Generation Sequencing
  10.5.5 Electrophoresis
  10.5.6 Chromatography
  10.5.7 Cell Counting
  10.5.8 Others
 10.6 Historic and Forecasted Market Size By End-Users
  10.6.1 Pharma-Biotech
  10.6.2 Agri & Food Industry
  10.6.3 Hospitals
  10.6.4 Bioinformatics
  10.6.5 Diagnostic Labs
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Biotechnology Instruments Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product Type
  11.4.1 Life Science Consumables
  11.4.2 In-Vitro Diagnostics {IVD} Instruments
  11.4.3 Medical Lasers
  11.4.4 Lab Automation Instruments
 11.5 Historic and Forecasted Market Size By Technology
  11.5.1 Spectroscopy
  11.5.2 Polymerase Chain Reaction {PCR}
  11.5.3 Liquid Handling
  11.5.4 Next-Generation Sequencing
  11.5.5 Electrophoresis
  11.5.6 Chromatography
  11.5.7 Cell Counting
  11.5.8 Others
 11.6 Historic and Forecasted Market Size By End-Users
  11.6.1 Pharma-Biotech
  11.6.2 Agri & Food Industry
  11.6.3 Hospitals
  11.6.4 Bioinformatics
  11.6.5 Diagnostic Labs
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Biotechnology Instruments Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product Type
  12.4.1 Life Science Consumables
  12.4.2 In-Vitro Diagnostics {IVD} Instruments
  12.4.3 Medical Lasers
  12.4.4 Lab Automation Instruments
 12.5 Historic and Forecasted Market Size By Technology
  12.5.1 Spectroscopy
  12.5.2 Polymerase Chain Reaction {PCR}
  12.5.3 Liquid Handling
  12.5.4 Next-Generation Sequencing
  12.5.5 Electrophoresis
  12.5.6 Chromatography
  12.5.7 Cell Counting
  12.5.8 Others
 12.6 Historic and Forecasted Market Size By End-Users
  12.6.1 Pharma-Biotech
  12.6.2 Agri & Food Industry
  12.6.3 Hospitals
  12.6.4 Bioinformatics
  12.6.5 Diagnostic Labs
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Biotechnology Instruments Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product Type
  13.4.1 Life Science Consumables
  13.4.2 In-Vitro Diagnostics {IVD} Instruments
  13.4.3 Medical Lasers
  13.4.4 Lab Automation Instruments
 13.5 Historic and Forecasted Market Size By Technology
  13.5.1 Spectroscopy
  13.5.2 Polymerase Chain Reaction {PCR}
  13.5.3 Liquid Handling
  13.5.4 Next-Generation Sequencing
  13.5.5 Electrophoresis
  13.5.6 Chromatography
  13.5.7 Cell Counting
  13.5.8 Others
 13.6 Historic and Forecasted Market Size By End-Users
  13.6.1 Pharma-Biotech
  13.6.2 Agri & Food Industry
  13.6.3 Hospitals
  13.6.4 Bioinformatics
  13.6.5 Diagnostic Labs
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Biotechnology Instruments Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Product Type
  14.4.1 Life Science Consumables
  14.4.2 In-Vitro Diagnostics {IVD} Instruments
  14.4.3 Medical Lasers
  14.4.4 Lab Automation Instruments
 14.5 Historic and Forecasted Market Size By Technology
  14.5.1 Spectroscopy
  14.5.2 Polymerase Chain Reaction {PCR}
  14.5.3 Liquid Handling
  14.5.4 Next-Generation Sequencing
  14.5.5 Electrophoresis
  14.5.6 Chromatography
  14.5.7 Cell Counting
  14.5.8 Others
 14.6 Historic and Forecasted Market Size By End-Users
  14.6.1 Pharma-Biotech
  14.6.2 Agri & Food Industry
  14.6.3 Hospitals
  14.6.4 Bioinformatics
  14.6.5 Diagnostic Labs
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

Global Biotechnology Instruments Market

Base Year:

2021

Forecast Period:

2022-2028

Historical Data:

2016 to 2020

Market Size in 2021:

USD 43.21 Bn.

Forecast Period 2022-28 CAGR:

5.4%

Market Size in 2028:

USD 62.44 Bn.

Segments Covered:

By Product Type

  • Life Science Consumables
  • IVD Instruments
  • Medical Lasers
  • Lab Automation Instruments

By Technology

  • Spectroscopy
  • Polymerase Chain Reaction {PCR}
  • Liquid Handling
  • Next-Generation Sequencing
  • Electrophoresis
  • Chromatography
  • Cell Counting
  • Others

By End Users

  • Pharma-Biotech
  • Agri And Food Industry
  • Hospitals
  • Bioinformatics
  • Diagnostic Labs

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Growing Demand for Biotechnology Instruments in Various Sectors

Key Market Restraints:

  • High Cost of Biotechnology Instrument

Key Opportunities:

  • Growing Technological Advancement

Companies Covered in the report:

  • Agilent Technologies, Inc. (the US), BD (Becton, Dickinson, and Company) (US), Bio-Rad Laboratories, Inc. (the US), Bruker (US), Danaher (US), and other major players.

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIOTECHNOLOGY INSTRUMENTS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIOTECHNOLOGY INSTRUMENTS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIOTECHNOLOGY INSTRUMENTS MARKET COMPETITIVE RIVALRY
TABLE 005. BIOTECHNOLOGY INSTRUMENTS MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIOTECHNOLOGY INSTRUMENTS MARKET THREAT OF SUBSTITUTES
TABLE 007. BIOTECHNOLOGY INSTRUMENTS MARKET BY PRODUCT TYPE
TABLE 008. LIFE SCIENCE CONSUMABLES MARKET OVERVIEW (2016-2028)
TABLE 009. IN-VITRO DIAGNOSTICS {IVD} INSTRUMENTS MARKET OVERVIEW (2016-2028)
TABLE 010. MEDICAL LASERS MARKET OVERVIEW (2016-2028)
TABLE 011. LAB AUTOMATION INSTRUMENTS MARKET OVERVIEW (2016-2028)
TABLE 012. BIOTECHNOLOGY INSTRUMENTS MARKET BY TECHNOLOGY
TABLE 013. SPECTROSCOPY MARKET OVERVIEW (2016-2028)
TABLE 014. POLYMERASE CHAIN REACTION {PCR} MARKET OVERVIEW (2016-2028)
TABLE 015. LIQUID HANDLING MARKET OVERVIEW (2016-2028)
TABLE 016. NEXT-GENERATION SEQUENCING MARKET OVERVIEW (2016-2028)
TABLE 017. ELECTROPHORESIS MARKET OVERVIEW (2016-2028)
TABLE 018. CHROMATOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 019. CELL COUNTING MARKET OVERVIEW (2016-2028)
TABLE 020. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 021. BIOTECHNOLOGY INSTRUMENTS MARKET BY END-USERS
TABLE 022. PHARMA-BIOTECH MARKET OVERVIEW (2016-2028)
TABLE 023. AGRI & FOOD INDUSTRY MARKET OVERVIEW (2016-2028)
TABLE 024. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 025. BIOINFORMATICS MARKET OVERVIEW (2016-2028)
TABLE 026. DIAGNOSTIC LABS MARKET OVERVIEW (2016-2028)
TABLE 027. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 028. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 029. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY END-USERS (2016-2028)
TABLE 030. N BIOTECHNOLOGY INSTRUMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 031. EUROPE BIOTECHNOLOGY INSTRUMENTS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 032. EUROPE BIOTECHNOLOGY INSTRUMENTS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 033. EUROPE BIOTECHNOLOGY INSTRUMENTS MARKET, BY END-USERS (2016-2028)
TABLE 034. BIOTECHNOLOGY INSTRUMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 035. ASIA PACIFIC BIOTECHNOLOGY INSTRUMENTS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 036. ASIA PACIFIC BIOTECHNOLOGY INSTRUMENTS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 037. ASIA PACIFIC BIOTECHNOLOGY INSTRUMENTS MARKET, BY END-USERS (2016-2028)
TABLE 038. BIOTECHNOLOGY INSTRUMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 041. MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY END-USERS (2016-2028)
TABLE 042. BIOTECHNOLOGY INSTRUMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 043. SOUTH AMERICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 044. SOUTH AMERICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 045. SOUTH AMERICA BIOTECHNOLOGY INSTRUMENTS MARKET, BY END-USERS (2016-2028)
TABLE 046. BIOTECHNOLOGY INSTRUMENTS MARKET, BY COUNTRY (2016-2028)
TABLE 047. ABBOTT: SNAPSHOT
TABLE 048. ABBOTT: BUSINESS PERFORMANCE
TABLE 049. ABBOTT: PRODUCT PORTFOLIO
TABLE 050. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. AGILENT TECHNOLOGIES: SNAPSHOT
TABLE 051. AGILENT TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 052. AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 053. AGILENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. ALCON INC.: SNAPSHOT
TABLE 054. ALCON INC.: BUSINESS PERFORMANCE
TABLE 055. ALCON INC.: PRODUCT PORTFOLIO
TABLE 056. ALCON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. ANGIODYNAMICS: SNAPSHOT
TABLE 057. ANGIODYNAMICS: BUSINESS PERFORMANCE
TABLE 058. ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 059. ANGIODYNAMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. BECTON: SNAPSHOT
TABLE 060. BECTON: BUSINESS PERFORMANCE
TABLE 061. BECTON: PRODUCT PORTFOLIO
TABLE 062. BECTON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. DICKINSON AND COMPANY: SNAPSHOT
TABLE 063. DICKINSON AND COMPANY: BUSINESS PERFORMANCE
TABLE 064. DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 065. DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. BIOMERIEUX SA: SNAPSHOT
TABLE 066. BIOMERIEUX SA: BUSINESS PERFORMANCE
TABLE 067. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 068. BIOMERIEUX SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. BIO-RAD LABORATORIES: SNAPSHOT
TABLE 069. BIO-RAD LABORATORIES: BUSINESS PERFORMANCE
TABLE 070. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 071. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. BIOTEK INSTRUMENTS INC.: SNAPSHOT
TABLE 072. BIOTEK INSTRUMENTS INC.: BUSINESS PERFORMANCE
TABLE 073. BIOTEK INSTRUMENTS INC.: PRODUCT PORTFOLIO
TABLE 074. BIOTEK INSTRUMENTS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. CANDELA MEDICAL: SNAPSHOT
TABLE 075. CANDELA MEDICAL: BUSINESS PERFORMANCE
TABLE 076. CANDELA MEDICAL: PRODUCT PORTFOLIO
TABLE 077. CANDELA MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. CYNOSURE LLC: SNAPSHOT
TABLE 078. CYNOSURE LLC: BUSINESS PERFORMANCE
TABLE 079. CYNOSURE LLC: PRODUCT PORTFOLIO
TABLE 080. CYNOSURE LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. DANAHER CORPORATION: SNAPSHOT
TABLE 081. DANAHER CORPORATION: BUSINESS PERFORMANCE
TABLE 082. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 083. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. ENDRESS+HAUSER (ANALYTIK JENA GMBH): SNAPSHOT
TABLE 084. ENDRESS+HAUSER (ANALYTIK JENA GMBH): BUSINESS PERFORMANCE
TABLE 085. ENDRESS+HAUSER (ANALYTIK JENA GMBH): PRODUCT PORTFOLIO
TABLE 086. ENDRESS+HAUSER (ANALYTIK JENA GMBH): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. F. HOFFMANN-LA ROCHE LTD.: SNAPSHOT
TABLE 087. F. HOFFMANN-LA ROCHE LTD.: BUSINESS PERFORMANCE
TABLE 088. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 089. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. IILUMINA INC.: SNAPSHOT
TABLE 090. IILUMINA INC.: BUSINESS PERFORMANCE
TABLE 091. IILUMINA INC.: PRODUCT PORTFOLIO
TABLE 092. IILUMINA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 092. IRIDEX: SNAPSHOT
TABLE 093. IRIDEX: BUSINESS PERFORMANCE
TABLE 094. IRIDEX: PRODUCT PORTFOLIO
TABLE 095. IRIDEX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 095. LUMENIS: SNAPSHOT
TABLE 096. LUMENIS: BUSINESS PERFORMANCE
TABLE 097. LUMENIS: PRODUCT PORTFOLIO
TABLE 098. LUMENIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 098. MERCK KGAA: SNAPSHOT
TABLE 099. MERCK KGAA: BUSINESS PERFORMANCE
TABLE 100. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 101. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. NOVANTA INC.: SNAPSHOT
TABLE 102. NOVANTA INC.: BUSINESS PERFORMANCE
TABLE 103. NOVANTA INC.: PRODUCT PORTFOLIO
TABLE 104. NOVANTA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. PERKIN ELMER INC.: SNAPSHOT
TABLE 105. PERKIN ELMER INC.: BUSINESS PERFORMANCE
TABLE 106. PERKIN ELMER INC.: PRODUCT PORTFOLIO
TABLE 107. PERKIN ELMER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. QIAGEN: SNAPSHOT
TABLE 108. QIAGEN: BUSINESS PERFORMANCE
TABLE 109. QIAGEN: PRODUCT PORTFOLIO
TABLE 110. QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. SIEMENS HEALTHINEERS: SNAPSHOT
TABLE 111. SIEMENS HEALTHINEERS: BUSINESS PERFORMANCE
TABLE 112. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 113. SIEMENS HEALTHINEERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113. TECAN GROUP AG: SNAPSHOT
TABLE 114. TECAN GROUP AG: BUSINESS PERFORMANCE
TABLE 115. TECAN GROUP AG: PRODUCT PORTFOLIO
TABLE 116. TECAN GROUP AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 116. THERMO FISHER SCIENTIFIC INC.: SNAPSHOT
TABLE 117. THERMO FISHER SCIENTIFIC INC.: BUSINESS PERFORMANCE
TABLE 118. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 119. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119. WATERS CORPORATION: SNAPSHOT
TABLE 120. WATERS CORPORATION: BUSINESS PERFORMANCE
TABLE 121. WATERS CORPORATION: PRODUCT PORTFOLIO
TABLE 122. WATERS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122. ZIMMER MEDIZINSYSTEME: SNAPSHOT
TABLE 123. ZIMMER MEDIZINSYSTEME: BUSINESS PERFORMANCE
TABLE 124. ZIMMER MEDIZINSYSTEME: PRODUCT PORTFOLIO
TABLE 125. ZIMMER MEDIZINSYSTEME: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 126. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 127. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 128. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. LIFE SCIENCE CONSUMABLES MARKET OVERVIEW (2016-2028)
FIGURE 013. IN-VITRO DIAGNOSTICS {IVD} INSTRUMENTS MARKET OVERVIEW (2016-2028)
FIGURE 014. MEDICAL LASERS MARKET OVERVIEW (2016-2028)
FIGURE 015. LAB AUTOMATION INSTRUMENTS MARKET OVERVIEW (2016-2028)
FIGURE 016. BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY TECHNOLOGY
FIGURE 017. SPECTROSCOPY MARKET OVERVIEW (2016-2028)
FIGURE 018. POLYMERASE CHAIN REACTION {PCR} MARKET OVERVIEW (2016-2028)
FIGURE 019. LIQUID HANDLING MARKET OVERVIEW (2016-2028)
FIGURE 020. NEXT-GENERATION SEQUENCING MARKET OVERVIEW (2016-2028)
FIGURE 021. ELECTROPHORESIS MARKET OVERVIEW (2016-2028)
FIGURE 022. CHROMATOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 023. CELL COUNTING MARKET OVERVIEW (2016-2028)
FIGURE 024. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 025. BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY END-USERS
FIGURE 026. PHARMA-BIOTECH MARKET OVERVIEW (2016-2028)
FIGURE 027. AGRI & FOOD INDUSTRY MARKET OVERVIEW (2016-2028)
FIGURE 028. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 029. BIOINFORMATICS MARKET OVERVIEW (2016-2028)
FIGURE 030. DIAGNOSTIC LABS MARKET OVERVIEW (2016-2028)
FIGURE 031. NORTH AMERICA BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. EUROPE BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. ASIA PACIFIC BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. MIDDLE EAST & AFRICA BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 035. SOUTH AMERICA BIOTECHNOLOGY INSTRUMENTS MARKET OVERVIEW BY COUNTRY (2016-2028)

Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Biotechnology Instruments Market research report?

The forecast period in the Biotechnology Instruments Market research report is 2022-2028.

Who are the key players in Biotechnology Instruments Market?

Agilent Technologies, Inc. (the US), BD (Becton, Dickinson, and Company) (US), Bio-Rad Laboratories, Inc. (the US), Bruker (US), Danaher (US), Eppendorf Corporate (Germany), General Electric Company (US), Hitachi High-Tech Corporation (Japan), Horiba (Japan), Merck KGaA (Germany), PerkinElmer Inc. (US), QIAGEN (Germany), Shimadzu Corporation (Japan), Thermo Fisher Scientific Inc. (US), and Waters Corporation (US), and other major players.

What are the segments of the Biotechnology Instruments Market?

The Biotechnology Instruments Market is segmented into Product Type, Technology, End Users, and region. By Product Type, the market is categorized into Life Science Consumables, In-Vitro Diagnostics {IVD} Instruments, Medical Lasers, and Lab Automation Instruments. By Technology the market is categorized into Spectroscopy, Polymerase Chain Reaction {PCR}, Liquid Handling, Next-Generation Sequencing, Electrophoresis, Chromatography, Cell Counting, and Others. By End-User the market is categorized into Pharma-Biotech, Agri & Food Industry, Hospitals, Bioinformatics, and Diagnostic Labs. By region, it is analyzed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Biotechnology Instruments Market?

Human civilization has been harnessing biological processes to enhance their standard of living for some 10,000 years, beginning with the first agricultural communities. Approximately 6,000 years ago, humans utilized the biological methods of microorganisms to make alcoholic beverages, bread, and cheese, and to preserve dairy products. Recently, due to the advent of biotechnology instruments, all these processes have become effortless and new technologies have been discovered to increase the yield.

How big is the Biotechnology Instruments Market?

The Global Biotechnology Instruments market was valued at USD 43.21 billion in 2021 and is expected to reach USD 62.44 billion by the year 2028, at a CAGR of 5.4%.